Gene · 427
Papers1,873
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,873
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Photocatalytic Semi-Hydrogenation of Alkynes: A Game of Kinetics, Selectivity and Critical Timing. | Nanomaterials (Basel) | 2023 | 37686898 | PubTator, text mining | PubMed |
| PROCEEDINGS OF THE XXIII CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: PadovaJune 8-10, 2023. | Acta Myol | 2023 | 37650038 | PubTator, text mining | PubMed |
| Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific. | Front Cell Infect Microbiol | 2023 | 37637460 | PubTator, text mining | PubMed |
| Acid Sphingomyelinase Deficiency Type B Patient-Derived Liver Organoids Reveals Altered Lysosomal Gene Expression and Lipid Homeostasis. | Int J Mol Sci | 2023 | 37628828 | PubTator, text mining | PubMed |
| Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm? | Int J Mol Sci | 2023 | 37628815 | PubTator, text mining | PubMed |
| Editorial: The Application of Proteogenomics to Urine Analysis for the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study. | Cancers (Basel) | 2023 | 37627171 | PubTator, text mining | PubMed |
| Genetics of enzymatic dysfunctions in metabolic disorders and cancer. | Front Oncol | 2023 | 37601653 | PubTator, text mining | PubMed |
| Targeting the deubiquitinase USP2 for malignant tumor therapy (Review). | Oncol Rep | 2023 | 37594087 | PubTator, text mining | PubMed |
| Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer. | Open Life Sci | 2023 | 37588994 | PubTator, text mining | PubMed |
| Identification of lysosomal genes associated with prognosis in lung adenocarcinoma. | Transl Lung Cancer Res | 2023 | 37577321 | PubTator, text mining | PubMed |
| YAP/TAZ: Molecular pathway and disease therapy. | MedComm (2020) | 2023 | 37576865 | PubTator, text mining | PubMed |
| Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction. | Respir Res | 2023 | 37568148 | PubTator, text mining | PubMed |
| Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19. | Cells | 2023 | 37566018 | PubTator, text mining | PubMed |
| Activity-Based Protein Profiling in Methicillin-Resistant Staphylococcus aureus Reveals the Broad Reactivity of a Carmofur-Derived Probe. | Chembiochem | 2023 | 37552008 | PubTator, text mining | PubMed |
| A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma. | Front Oncol | 2023 | 37538124 | PubTator, text mining | PubMed |
| An intestinal sphingolipid confers intergenerational neuroprotection. | Nat Cell Biol | 2023 | 37537365 | PubTator, text mining | PubMed |
| Neutral ceramidase-active site inhibitor chemotypes and binding modes. | Bioorg Chem | 2023 | 37531819 | PubTator, text mining | PubMed |
| Long-range PCR amplification-based targeted enrichment & next generation sequencing: A cost-effective testing strategy for lysosomal storage disorders. | Indian J Med Res | 2023 | 37530313 | PubTator, text mining | PubMed |
| The potential role of acid ceramidase in oral squamous cell carcinoma chemo-resistance by inducing autophagy. | Hum Cell | 2023 | 37515715 | PubTator, text mining | PubMed |
| Phenotype Presentation and Molecular Diagnostic Yield in Non-5q Spinal Muscular Atrophy. | Neurol Genet | 2023 | 37470033 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/427/papers?page=10